Here’s the direct answer: at Parker Neuroscience, IV ketamine, not Spravato, is the option used off-label for anxiety. Spravato’s FDA approval is specific to treatment-resistant depression and MDD with acute suicidal ideation, not anxiety on its own. IV ketamine works through a different pathway than most anxiety medications, targeting the brain’s glutamate system rather than serotonin, which is part of why it’s being studied for anxiety that hasn’t responded well to standard treatment. Whether it’s appropriate for you depends on a full clinical evaluation, not a blanket yes.
How Ketamine Works for Anxiety
Most anxiety medications work on the serotonin system, the same target as standard antidepressants. Ketamine works differently: it acts on NMDA receptors in the glutamate system, the brain’s most abundant neurotransmitter pathway. This has led researchers to study ketamine’s effects on anxiety specifically, not just depression, since glutamate signaling is increasingly understood to play a role in anxiety and fear-related processing. A peer-reviewed neuroimaging study published in Frontiers in Psychiatry looked directly at how ketamine affects glutamate activity in the brain, part of the broader research base behind why this pathway is being studied for anxiety.
Is Spravato an Option for Anxiety?
Not on its own. Spravato is FDA-approved for treatment-resistant depression and MDD with acute suicidal ideation, not as a primary treatment for anxiety. If anxiety is present alongside depression, Dr. Parker evaluates the full clinical picture and discusses which treatment pathway, Spravato, IV ketamine, or something else, actually fits. For anxiety on its own, IV ketamine is the treatment under consideration, used off-label after a full evaluation.
What Candidacy Looks Like
Not every patient is a candidate for ketamine-based care, and a responsible clinic should tell you that upfront rather than after you’ve already started. Before treatment is considered, Parker Neuroscience reviews your psychiatric history, current medications, medical risk factors, and safety considerations, the same evaluation process used across every treatment pathway at the practice, applied here to your anxiety symptoms specifically. Details on how IV ketamine therapy works, and what the anxiety treatment pathway looks like specifically, are covered on those pages.
What Treatment Looks Like
If IV ketamine is recommended, the front half of the experience looks the same as it does for any other diagnosis treated at Parker Neuroscience: a thorough evaluation, baseline vitals, a private and monitored treatment setting, and a ride home arranged in advance. The full walk-through of what a session actually feels like is covered in the first appointment guide.
Setting Realistic Expectations
Ketamine-based treatment is sometimes talked about online as an instant fix. That isn’t a responsible way to think about it. Some patients experience meaningful improvement, others have partial improvement, and some don’t respond, the same variability that shows up across every diagnosis ketamine is used to treat, not just anxiety. A closer look at why response varies from patient to patient, and why timing and expectations matter, is covered in why ketamine helps some patients more than others.
Questions related to this one
Does ketamine actually work for anxiety, or just depression? Ketamine is primarily studied and used for treatment-resistant depression, but research has also looked at its effects on anxiety specifically, since it acts on the glutamate system rather than serotonin. At Parker Neuroscience, IV ketamine is used off-label for anxiety after a full clinical evaluation determines it’s an appropriate option.
Is Spravato an option for anxiety? Not on its own. Spravato is FDA-approved for treatment-resistant depression and MDD with acute suicidal ideation, not as a primary anxiety treatment. If anxiety is present alongside depression, that’s part of the full clinical picture Dr. Parker evaluates before recommending a treatment path.
What does candidacy for IV ketamine involve? Candidacy is determined through a clinical evaluation that reviews your psychiatric history, current medications, medical risk factors, and overall safety profile. Not every patient is a candidate, and if ketamine-based treatment isn’t the right fit, that’s communicated directly rather than glossed over.
How soon might I notice a difference? It varies by patient. Some notice change within the first few sessions, while for others meaningful change builds gradually across a series. Response is tracked throughout treatment rather than left to guesswork.